Health values before and after pacemaker implantation

American Heart Journal

Volumn 144, Issue 4, 2002, Pages 687-692

  Lopez Jimenez, Francisco ^a   Goldman, Lee ^b   Orav, E John ^c   Ellenbogen, Kenneth ^d   Stambler, Bruce ^g   Marinchak, Roger ^h   Wilkoff, Bruce L ^e   Mangione, Carol M ^f   Yoon, Catherine ^c   Vitale, Kimberly ^a   Lamas, Gervasio A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h LANKENAU HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ANGINA PECTORIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; ELDERLY CARE; EMPLOYMENT; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GENDER; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SINUS NODE DISEASE; STATISTICAL SIGNIFICANCE; TIME;

EID: 0036792175     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)00143-6     Document Type: Article

References (22)

1. Drummond MF, Stoddart GL, Torrance GW. Methods of the economic evaluation of health care programs. Oxford: Oxford University Press; 1987. p. 74-111.
2. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
3. Weinstein MC, Fineberg HV. Clinical decision making. Philadelphia: WB Saunders; 1980. p. 184-226.
4. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998;338: 1097-104.
5. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:117-33.
6. Tsevat J, Dawson NV, Matchar DB. Assessing quality of life and preferences in the seriously ill using utility theory. J Clin Epidemiol 1990;43(Suppl):73-7S.
7. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
8. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press; 1949. p. 199-205.
9. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
10. Goldman L, Hashimoto B, Cook EF, et al. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981;64:1227-33.
11. Lee TH, Shammash JB, Ribiero JP, et al. Estimation of maximum oxygen uptake from clinical data: performance of the Specific Activity Scale. Am Heart J 1988;115:203-4.
12. Tsevat J, Weeks JC, Guadagnoli E, et al. Using health-related quality of life information: clinical encounters, clinical trials, and health policy. J Gen Intern Med 1994;9:576-82.
13. Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York: Oxford University Press; 1982.
14. Johannesson M, Pliskin JS, Weinstein MC. A note on QALYs, time tradeoff, and discounting. Med Decis Making 1994;14:188-93.
15. Gold MR, Franks P, McCoy KI, et al. Toward consistency in cast-utility analyses using national measures to create condition-specific values. Med Care 1998;36:779-92.
16. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998;80:189-94.
17. Mathias SD, Bates MM, Pasta DJ, et al. Use of the Health Utilities Index with stroke patients and their caregivers. Stroke 1997;28:1888-94.
18. Tsevat J, Goldman L, Lamas GA, et al. Functional status versus utilities in survivors of myocardial infarction. Med Care 1991;29:1153-9.
19. Bennett KJ, Torrance GW, Moran LA, et al. Health state utilities in knee replacement surgery: the development and evaluation of Mcknee. J Rheumatol 1997;24:1796-805.
20. Yoon C, Lopez-Jimenez F, Orav J, et al. Quality of life improvement 3 months following pacemaker implantation in elderly patients [abstract]. PACE 1998;21(Suppl):976.
21. Ernst E, Resch KL. Concept of the perceived placebo effects. BMJ 1995;311:551-3.
22. Ellenbogen KA, Stambler B, Orav EJ, et al. Clinical characteristics of patients intolerant to VVIR pacing. Am J Cardiol 2000;86:59-63.